Szalai, Eszter Ágnes http://orcid.org/0000-0003-2276-7109
Teutsch, Brigitta
Babay, Viktória
Galvács, Adél
Hegyi, Péter
Hársfalvi, Péter
Pál, Róbert
Varga, Gábor http://orcid.org/0000-0002-5506-8198
Lohinai, Zsolt M.
Kerémi, Beáta http://orcid.org/0000-0003-4000-9440
Funding for this research was provided by:
Faculty of Dentistry
ÚNKP-22-3 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund
Article History
Received: 21 February 2024
Revised: 22 April 2024
Accepted: 23 April 2024
First Online: 20 May 2024
Competing interests
: The authors declare no competing interests.
: The protocol has been approved by the National Institute of Pharmacy and Nutrition (OGYÉI) (838). The study will be performed following the declaration of Helsinki (International Conference on Harmonization and Good Clinical Practice guidelines). All eligible participants will receive verbal and written information about the objectives and products of the study before being asked to sign an electronic informed consent form. Participants will have the opportunity to ask the medical personnel any questions that may arise and refuse to participate. After signing the Hungarian version of the Study Participation Consent Form and Patient Information Leaflet, eligible participants will be randomized on the electronic platform (REDCap (Research Electronic Data Capture)). Project team members will have access solely to the blinded data, which will be handled confidentially.